For adults, the device can be used in combination with surgical or other required interventions. Credit: Jo Panuwat D / Shutterstock.

Align Technology has gained approval for its orthodontic device, the Invisalign Palatal Expander System, from the Turkish Medicines and Medical Device Agency (TMMDA), making it commercially available nationwide.

This approval marks an advancement in orthodontic treatment options, catering to a broad range of patients.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Designed for the “rapid” expansion and maintenance of a narrow maxilla (upper jaw), the device is used to treat individuals with primary, mixed or permanent dentition.

It is a direct 3D-printed system based on patented technology, providing a customised treatment plan for each patient.

The device is developed using Align’s orthodontic software, following a digital scan of the patient’s mouth with an iTero intraoral scanner.

It is part of Align’s comprehensive solution for early orthodontic intervention, known as Phase I treatment.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The Invisalign Palatal Expander, along with Invisalign First aligners, claims to offer a complete treatment solution for young individuals.

These aligners are specifically designed for younger patients with various malocclusions, including those with erupting dentition and the need for dental arch expansion.

For adults, the device can be combined with surgical or other required interventions. They are removable, facilitating better oral hygiene, and can be changed daily without the need for screws.

Align Technology Europe, Middle East, and Africa (EMEA) executive vice-president and managing director Simon Beard said: “The Invisalign Palatal Expander System exemplifies Align’s ongoing dedication to pioneering digital orthodontics.

“It offers enhanced efficiency for doctors and improved treatment experiences for young patients. We are excited to make this innovative 3D printed alternative to traditional palatal expanders available to even more doctors and their patients across the EMEA region.”

The device is currently available in markets, including Canada, the European Union, Hong Kong, Singapore, Switzerland, the UK and the US.

Align anticipates further expansion of the product’s availability, subject to regulatory approvals in additional markets.

In December 2023, the company received 510(k) clearance from the US Food and Drug Administration for the Invisalign Palatal Expander System.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact